| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.826 | 27.909 | 67.630 | 84.869 | 143.166 | 139.132 | 149.040 | 155.646 | 204.025 | 183.878 |
| Total Income - EUR | 20.338 | 28.817 | 68.495 | 86.826 | 163.367 | 143.596 | 155.978 | 160.904 | 239.638 | 193.866 |
| Total Expenses - EUR | 12.305 | 20.840 | 48.367 | 61.051 | 106.569 | 98.521 | 141.967 | 108.449 | 155.475 | 149.485 |
| Gross Profit/Loss - EUR | 8.034 | 7.977 | 20.128 | 25.775 | 56.798 | 45.075 | 14.011 | 52.455 | 84.163 | 44.382 |
| Net Profit/Loss - EUR | 7.423 | 7.221 | 18.400 | 24.908 | 55.165 | 43.553 | 12.508 | 49.878 | 81.952 | 39.138 |
| Employees | 0 | 1 | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 2 |
Check the financial reports for the company - Xpill-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.182 | 6.040 | 17.785 | 100.753 | 153.255 | 156.420 | 195.570 | 172.347 | 204.303 | 187.099 |
| Current Assets | 29.957 | 40.883 | 42.872 | 76.006 | 98.767 | 139.070 | 134.913 | 95.603 | 157.627 | 119.293 |
| Inventories | 20.317 | 25.047 | 28.391 | 37.997 | 50.394 | 42.456 | 26.997 | 39.292 | 46.998 | 22.399 |
| Receivables | 4.308 | 9.775 | 6.455 | 6.877 | 18.585 | 11.005 | 48.670 | 46.634 | 104.873 | 94.878 |
| Cash | 5.332 | 6.061 | 8.026 | 31.131 | 29.788 | 85.610 | 59.247 | 9.677 | 5.757 | 2.015 |
| Shareholders Funds | 2.186 | 9.385 | 27.632 | 52.046 | 106.203 | 136.165 | 109.488 | 58.317 | 122.980 | 60.915 |
| Social Capital | 45 | 45 | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 33.953 | 37.658 | 33.371 | 125.435 | 147.919 | 162.293 | 224.679 | 217.264 | 243.127 | 247.346 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.211 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Xpill-Med Srl